Epidemiology of Reopening in the COVID-19 Pandemic in the United States, Europe and Asia
Weiqi Zhang, Alina Oltean, Scott Nichols, Fuad Odeh, Fei Zhong
doi: https://doi.org/10.1101/2020.08.05.20168757
Weiqi Zhang
1Merck Holding (China), Shanghai, China, a business of Merck KGaA, Darmstadt, Germany
Alina Oltean
2MilliporeSigma, St. Louis, Missouri, a business of Merck KGaA, Darmstadt, Germany
Scott Nichols
2MilliporeSigma, St. Louis, Missouri, a business of Merck KGaA, Darmstadt, Germany
Fuad Odeh
2MilliporeSigma, St. Louis, Missouri, a business of Merck KGaA, Darmstadt, Germany
Fei Zhong
2MilliporeSigma, St. Louis, Missouri, a business of Merck KGaA, Darmstadt, Germany
Posted August 06, 2020.
Epidemiology of Reopening in the COVID-19 Pandemic in the United States, Europe and Asia
Weiqi Zhang, Alina Oltean, Scott Nichols, Fuad Odeh, Fei Zhong
medRxiv 2020.08.05.20168757; doi: https://doi.org/10.1101/2020.08.05.20168757
Subject Area
Subject Areas
- Addiction Medicine (408)
- Allergy and Immunology (720)
- Anesthesia (214)
- Cardiovascular Medicine (3042)
- Dermatology (258)
- Emergency Medicine (456)
- Epidemiology (12963)
- Forensic Medicine (12)
- Gastroenterology (848)
- Genetic and Genomic Medicine (4772)
- Geriatric Medicine (440)
- Health Economics (747)
- Health Informatics (3028)
- Health Policy (1096)
- Hematology (405)
- HIV/AIDS (952)
- Medical Education (450)
- Medical Ethics (119)
- Nephrology (490)
- Neurology (4544)
- Nursing (242)
- Nutrition (671)
- Oncology (2364)
- Ophthalmology (666)
- Orthopedics (264)
- Otolaryngology (332)
- Pain Medicine (296)
- Palliative Medicine (86)
- Pathology (512)
- Pediatrics (1232)
- Primary Care Research (515)
- Public and Global Health (7136)
- Radiology and Imaging (1587)
- Respiratory Medicine (940)
- Rheumatology (456)
- Sports Medicine (396)
- Surgery (504)
- Toxicology (63)
- Transplantation (218)
- Urology (187)